Status: Recruiting
Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
This is an international, multicenter, randomized, open, Phase III trial to evaluate the efficacy and safety of carboplatin/paclitaxel/bevacizumab followed by bevacizumab and niraparib compared to carboplatin/paclitaxel followed by niraparib in patients with newly diagnosed advanced ovarian cancer.
Participants needed: 970
Trial details
Phase: Phase 3Age: 18+Biological sex: FemaleType: InterventionalSponsor: AGO Study GroupUpdated: Sep 10, 2025Locations: 65
Eligibility criteria
Signed written informed consent obtained prior to initiation of any study-specif... [+22]
Non-epithelial tumor origin of the ovary. [+37]